Amodiaquine Hydrochloride API (CAS 6398-98-7): Uses, Manufacturers, Suppliers & Global Market Trends

Introduction to Amodiaquine Hydrochloride

What is Amodiaquine Hydrochloride?

In the global fight against malaria, Amodiaquine Hydrochloride (CAS 6398-98-7) has emerged as a crucial pharmaceutical compound. If you are part of the pharmaceutical industry—whether as a manufacturer, exporter, or procurement specialist—this API is one you simply cannot ignore.

Amodiaquine-Hydrochloride-API-CAS-6398-98-7-Uses-Manufacturers-Suppliers-Global-Market-Trends

Amodiaquine Hydrochloride is a widely used antimalarial API, particularly effective against Plasmodium falciparum, the parasite responsible for the most severe form of malaria. It is often used in combination therapies, especially with artesunate, to improve treatment outcomes and reduce drug resistance. 

What makes this compound particularly valuable is its cost-effectiveness and strong therapeutic efficacy, making it a preferred choice in malaria-endemic regions such as Africa, Southeast Asia, and parts of South America. As global health organizations continue to push for malaria eradication, the demand for Amodiaquine Hydrochloride manufacturers and suppliers continues to rise steadily.

Chemical Identification & CAS Details

Amodiaquine Hydrochloride is identified by CAS No: 6398-98-7, ensuring standardized recognition across global pharmaceutical and regulatory systems. It belongs to the 4-aminoquinoline class of compounds, similar to chloroquine, but with improved activity against resistant strains.

Its chemical structure allows it to accumulate in the parasite’s food vacuole, disrupting essential biological processes. This makes it highly effective in killing the parasite and controlling infection.

For manufacturers, ensuring high purity, stability, and compliance is essential. Regulatory authorities require comprehensive documentation, including COA, MSDS, and impurity profiles. Quality deviations can directly impact treatment outcomes, making strict quality control a necessity.

Mechanism of Action

Antimalarial Activity

Amodiaquine works by interfering with the parasite’s ability to detoxify heme, a toxic byproduct formed during the digestion of hemoglobin. By preventing this detoxification process, the drug causes accumulation of toxic substances within the parasite, ultimately leading to its death.

This targeted mechanism makes Amodiaquine highly effective against malaria parasites, especially when used in combination with other antimalarial drugs.

Clinical Importance in Malaria Treatment

In clinical practice, Amodiaquine is rarely used alone. Instead, it is commonly combined with artesunate in Artemisinin-based Combination Therapies (ACTs), which are recommended by global health organizations.

This combination enhances treatment efficacy, reduces resistance, and improves patient outcomes. It is widely used in national malaria control programs across multiple countries.

Key Applications

Treatment of Malaria

The primary application of Amodiaquine Hydrochloride is in the treatment of uncomplicated malaria, particularly caused by Plasmodium falciparum. It is effective in both acute treatment and prevention strategies in endemic regions.

Combination Therapy Use

Amodiaquine is most commonly used in combination with artesunate, forming one of the most widely recommended ACT regimens. This combination therapy is crucial in reducing malaria-related mortality rates worldwide.

Dosage Forms & Strengths

Tablet & Suspension Forms

Amodiaquine Hydrochloride is available in various formulations, including:

• Tablets (typically 153 mg equivalent base)
• Oral suspensions for pediatric use

These forms allow flexible dosing across different age groups.

Market Demand by Formulation

Tablets dominate the market due to ease of distribution and storage, while suspensions are preferred for pediatric patients in malaria-endemic regions.

Global Market Overview

Market Growth & Trends

The global Amodiaquine Hydrochloride API market is driven by ongoing malaria control initiatives and government healthcare programs. Organizations such as WHO and UNICEF play a significant role in procurement and distribution.

Regional Demand Insights

Region	Market Trend
Africa	Highest demand
Asia-Pacific	Growing market
Latin America	Moderate demand
Others	Emerging regions

Africa remains the largest market due to the high prevalence of malaria.

Manufacturing Process Overview

API Production Stages

The manufacturing process involves chemical synthesis, purification, and formulation. Each stage requires strict control to ensure product quality and efficacy.

Quality Control Measures

Quality assurance includes testing for purity, stability, and compliance with international standards. Analytical methods such as HPLC are commonly used.

Regulatory Compliance

GMP & International Standards

Manufacturers must comply with GMP, WHO prequalification, and international regulatory guidelines to participate in global supply programs.

Benefits of Amodiaquine API

Amodiaquine offers several advantages, including high efficacy against malaria, affordability, and strong demand from global health programs. Its role in combination therapy further enhances its importance.

Challenges in Market

Challenges include drug resistance concerns, regulatory requirements, and dependency on government procurement programs. Manufacturers must adapt to evolving guidelines.

Demand Drivers

Global malaria eradication efforts, increasing healthcare funding, and rising awareness are key drivers for this API’s demand.

Choosing a Reliable Supplier

Selecting a supplier involves evaluating quality certifications, regulatory compliance, and supply consistency. A reliable partner ensures uninterrupted supply for critical healthcare programs.

Company Overview – Swapnroop Drugs & Pharmaceuticals

At Swapnroop Drugs and Pharmaceuticals, we take pride in being a trusted global supplier of pharmaceutical raw materials — delivering excellence, reliability, and regulatory compliance since 2013.

We specialize in supplying high-quality APIs and intermediates with complete documentation and consistent supply. Our commitment to quality and customer satisfaction makes us a preferred partner for pharmaceutical companies worldwide.

Conclusion

Amodiaquine Hydrochloride (CAS 6398-98-7) plays a vital role in global malaria treatment strategies. Its effectiveness, affordability, and inclusion in combination therapies make it indispensable in public health programs.

For manufacturers and suppliers, this API offers strong market potential driven by global demand and healthcare initiatives. Ensuring quality, compliance, and reliable supply is key to success in this competitive market.

FAQs

1. What is Amodiaquine Hydrochloride used for?

It is used to treat malaria, especially in combination with artesunate.

2. What is the CAS number of Amodiaquine Hydrochloride?

The CAS number is 6398-98-7.

3. Is Amodiaquine used alone?

It is usually used in combination therapy to improve effectiveness and reduce resistance.

4. Where is demand highest?

Demand is highest in malaria-endemic regions, especially Africa.

5. Who are reliable Amodiaquine API suppliers?

Certified pharmaceutical companies like Swapnroop Drugs and Pharmaceuticals.

6. Why choose Swapnroop Drugs and Pharmaceuticals?

At Swapnroop Drugs and Pharmaceuticals, we take pride in being a trusted global supplier of pharmaceutical raw materials — delivering excellence, reliability, and regulatory compliance since 2013.